An examination of layoffs in pharmaceutical and biotechnology companies in Q3 shows that as the summer progressed, the number ...

Gilead Merger AstraZeneca, the UK’s largest drugmaker valued at $140bn, has reportedly contacted Gilead Sciences, an American ...

On 9 September the US House of Representatives passed the draft of the Biosecure Act, which aims to prohibit US pharma ...

The company described the move as a “mass layoff of its sales representatives and related employees across the country,” ...

Mylan Pharmaceuticals Inc and Novo Nordisk, the original patent holder for Ozempic, have reached a settlement in the US ...

VanEck Pharmaceutical ETF has shown strong performance but faces near-term downside risks, prompting a rating downgrade to ...

The strong up move was seen in the stock price with the scrip touching the day's high of Rs 1,408.70 per share on the NSE, ...

Patient groups should be playing a central role in Canada's health-care system, advocating for their members by promoting the ...

Sun Pharmaceutical Industries has extended its partnership with Philogen. With the latest agreement, Sun Pharma will ...

According to data from the BSE index, the stock has achieved multibagger gains over the last two years, climbing 122.04%.

The partnership will combine Real Chemistry’s consultative and strategic expertise with Corval’s commercialization planning ...

Piramal Pharma Ltd. expects new molecule development and an $80 million expansion of its sterile injectable facility in ...